Your browser doesn't support javascript.
loading
Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib - Case report.
Barrett, Aisling; Eyre, Toby A; Bhuva, Shaheel; Aljurf, Mahmoud; Fakih, Riad El; Ashshi, Mohammad A; Alshaibani, Alfadel.
Afiliação
  • Barrett A; Department of Clinical Haematology Oxford Cancer and Haematology Centre Oxford University Hospitals NHS Foundation Trust Oxford UK.
  • Eyre TA; Department of Clinical Haematology Oxford Cancer and Haematology Centre Oxford University Hospitals NHS Foundation Trust Oxford UK.
  • Bhuva S; Department of Clinical Radiology Oxford University Hospitals NHS Foundation Trust Oxford UK.
  • Aljurf M; Department of Stem Cell Transplant and Cellular Therapy King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia.
  • Fakih RE; Department of Stem Cell Transplant and Cellular Therapy King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia.
  • Ashshi MA; College of Medicine Umm Al-Qura University Makkah Saudi Arabia.
  • Alshaibani A; Department of Stem Cell Transplant and Cellular Therapy King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia.
EJHaem ; 5(1): 238-241, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38406527
ABSTRACT
Central nervous system (CNS) involvement by mantle cell lymphoma (MCL) is rare and portends a poor prognosis. We describe the first patient to have a complete response with front-line treatment with single-agent acalabrutinib for MCL CNS.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article